A Healthy Volunteer Pharmacokinetics (PK)/Pharmacodynamics (PD), Safety and Tolerability Study of Andexanet in Healthy Japanese and Caucasian Subjects

NCT03310021 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Bleeding

Interventions

BIOLOGICAL: Andexanet alfa
DRUG: Apixaban
DRUG: Rivaroxaban
DRUG: Edoxaban
DRUG: Placebo

Sponsor

Portola Pharmaceuticals